OasisLMS

Managing HF Across the Spectrum: From Recognizing Symptoms to Implementing Appropriate Treatment

What You Will Learn

• Evaluate the epidemiology, risk factors, comorbidities, and community aspects associated with Heart Failure (HF) to determine best practices for care.
• Distinguish pathophysiologic characteristics when evaluating and diagnosing HF, including current classifications, genotypes, and phenotypes, to best analyze HF risk stratification, prevention, and management strategies.  
• Incorporate Guideline-Directed Medical Therapy (GDMT), newer therapies, and interprofessional team strategies into treatment care plans for the management of HF to improve care coordination, communication, and patient outcomes. 

We are grateful to these distinguished faculty who contributed to this collection:

Chair

Alison Bailey, MD, FACC
Melvin R. Echols, MD, FACC

Faculty

Vanessa Blumer, MD, FACC
Biykem Bozkurt, MD, PhD, FACC
Javed Butler, MBBS, MPH, MBA, FACC
Katherine Crawford, PharmD, BCCP, AACC
Leslie L. Davis, NP, PhD, FACC
Ersilia M. DeFilippis, MD, FACC, FAHA, FHFSA
Roberta Florido, MD, MHS
Michelle M. Kittleson, MD, PhD, FACC
Selma F. Mohammed, MBBS, FACC
George G. Sokos, DO, FACC
Estefania Oliveros Soles, MD, MSc, FACC, FAHA, FACP
Justin M. Vader, MD, FACC
Clyde W. Yancy, MD, MSc, MACC

Educational Grant Support Provided By: Bayer AG

Page Launched: August 28, 2025